CoChat

Double‐blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients

Nemeroff, Charles B., Ninan, Philip T., Ballenger, James, Lydiard, R. Bruce, Feighner, John, Patterson, William M., Greist, John H. · 1995 · Depression
Cited by 51

The DOI matches its Crossref record.

Abstract

Fluvoxamine and sertraline, both selective serotonin reuptake inhibitors (SSRIs), were compared in a 5‐center, 7‐week double‐blind study in outpatients with major depression diagnosed by DSM‐III‐R criteria. Ninety‐five patients were titrated from 50 to 150 mg/day offluvoxamine (n = 49) or 50 to 200 mg/day of sertraline (n = 46). The mean dose administered in Weeks 3‐1 was 123.8 mg/day for fluvoxamine, and 137.1 mg/day for sertraline. Forty‐seven percent (47%) of fluvoxamine‐treated patients and 30% of sertraline‐treated patients were titrated to the maximum permissible dose. Fluvoxamine and sertraline were similarly effective in ameliorating depression as demonstrated by a mean reduction from baseline in the Hamilton Rating Scale for Depression (HAMD) total score of 10.61 ± 7.53 and 10.98 ± 6.08, respectively. Adverse events, mostly mild to moderate in severity, were reported for 93.5% of sertraline patients and 85.7% offluvoxamine patients. The most common events in the sertraline group were insomnia (34.8%), headache (32.6%), diarrhea (23.9%), and ejaculatory difficulty (22.2% of males), and in the fluvoxamine group, nausea (30.6%), headache (26.5%), insomnia (26.5%), and somnolence (24.5%). Significantly more patients reported sexual dysfunction in the sertraline (28%) than in the fluvoxamine (10%) group. An uncharacteristically low dropout rate due to adverse events was observed in the sertraline group (2.2%) compared with the fluvoxamine group (18.4%). The rate of withdrawal due to adverse events in the fluvoxamine group (0–2 patients/center) was comparable to that in the sertraline group (1 patient) for four of the five centers; the fifth center had 4 withdrawals in the fluvoxamine group. The differences in clinical profile of these two SSRIs provide physicians with meaningful choices in antidepressant therapy attuned to individual patient characteristics. Depression 3:163–169 (1995). © 1995 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/depr.3050030402

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 51

Metadata

Authors
Nemeroff, C. B., Ninan, P. T., Ballenger, J., Lydiard, R. B., Feighner, J., Patterson, W. M., & Greist, J. H.
Venue
Depression
Publisher
Wiley
Published
1995-01
Volume
3
Issue
4
Pages
163-169
ISSN
  • 1062-6417 (ISSN-L)
  • 1522-7162
OpenAlex
W2066145256
Cited by
51
References
0
FWCI
1.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Double‐blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients. https://app.cochat.ai/papers/10.1002/depr.3050030402
The paper
Nemeroff, C. B., Ninan, P. T., Ballenger, J., Lydiard, R. B., Feighner, J., Patterson, W. M., & Greist, J. H. (1995). Double‐blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients. Depression. https://doi.org/10.1002/depr.3050030402

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.